ANI Pharmaceuticals | ANIP - Zysk Brutto Na Sprzedaży





Zysk Brutto Na Sprzedaży Zmiana Data
AbbVie USD 12.54B 474M 2026-03
ANI Pharmaceuticals USD 124.18M 12.39M 2025-12
Assertio Holdings USD 22.24M 970K 2024-06
Aurora Cannabis CAD 46.62M 14.33M 2025-12
Canopy Growth CAD 21.47M 434K 2025-12
Eli Lilly USD 15.92B 1.33B 2025-12
Heron Therapeutics USD 29.47M 3.17M 2025-12
Hikma Pharmaceutical USD 362.5M 329.5M 2025-06
Knight Therapeutics CAD 64.72M 8.91M 2025-12
Nektar Therapeutics USD 21.81M 8.06M 2025-12
Novartis USD 10.82B 694M 2025-09
Omeros USD -33.16M 18.52M 2024-06
Perrigo USD 362.2M 14.9M 2025-12
Sun Pharmaceuticals INR 107.66B 2.05B 2025-09
Teva Pharmaceutical Industries USD 2.11B 547M 2026-03